Doxazosin alone or versus in combination with celecoxib in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.

Trial Profile

Doxazosin alone or versus in combination with celecoxib in men with lower urinary tract symptoms associated with benign prostatic hyperplasia.

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Jul 2012

At a glance

  • Drugs Celecoxib (Primary) ; Doxazosin
  • Indications Benign prostatic hyperplasia; Lower urinary tract symptoms
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Jul 2012 New trial record
    • 24 May 2012 Results presented at the 107th Annual Meeting of the American Urological Association.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top